Regulations.gov document
Agency Information Collection Activities; Submission for Office of Management and Budget…
Notice · FDA-2021-N-0515 · posted Nov 5, 2021
Key facts
| Document ID | FDA-2021-N-0515-0002 |
|---|---|
| Title | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Postmarketing Adverse Experience Reporting and Recordkeeping for Drug and Biological Products |
| Document type | Notice |
| Subtype | 30 Day Proposed Information Collection |
| Agency | FDA |
| Docket | FDA-2021-N-0515 |
| Posted | Nov 5, 2021 |
| Federal Register citation | 86 FR 61277 |
| FR document number | 2021-24236 |
| Comment period opens | Nov 5, 2021 |
| Comments due | Dec 7, 2021 |
| Effective date | Nov 5, 2021 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: